Q2
AIFF — Q2 2026 Financial Report Analysis
Firefly Neuroscience Q2 2026: revenue rose 72% to $514K (+26% like-for-like after the Evoke deal) and the net loss widened to $1.98M; a $10.25M raise lifted cash to $9.2M, about 15 months of burn, but the going-concern warning remains.